JJ PHARMA

JJ Pharma, Inc., a biotechnology company, produces microbial fermentations for therapeutic fields.

JJ Pharma, Inc., a biotechnology company, produces microbial fermentations for therapeutic fields. The company primarily focuses on developing drug compounds for cardiovascular and arthritis diseases, as well as cancer and tuberculosis. It offers JJP-10 and JJP-11, which are water-soluble cholesterol altering compounds that minimize liver and muscle toxicity, as well as prevent drug interactions; and JJP-12, a water-soluble small molecule produced from microorganisms that reduces arthritis. JJ Pharma, Inc. was founded in 2004 and is based in San Francisco, California.